Friedman A - Search Results

1

Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra.

Galazka-Friedman J, Bauminger ER, Koziorowski D, Friedman A. Galazka-Friedman J, et al. Among authors: friedman a. Biochim Biophys Acta. 2004 Mar 2;1688(2):130-6. doi: 10.1016/j.bbadis.2003.11.005. Biochim Biophys Acta. 2004. PMID: 14990343 Free article.

2

[Mossbauer spectroscopy of iron in substantia nigra in Parkinson disease and controls].

Friedman A, Bauminger ER, Gałazka-Friedman J, Barcikowska M, Suwalski J, Hechel D, Dymecki J, Nowik I. Friedman A, et al. Neurol Neurochir Pol. 1994;28(1 Suppl 1):145-55. Neurol Neurochir Pol. 1994. PMID: 8065540 Polish.

3

Iron in parkinsonian and control substantia nigra--a Mössbauer spectroscopy study.

Gałazka-Friedman J, Bauminger ER, Friedman A, Barcikowska M, Hechel D, Nowik I. Gałazka-Friedman J, et al. Among authors: friedman a. Mov Disord. 1996 Jan;11(1):8-16. doi: 10.1002/mds.870110104. Mov Disord. 1996. PMID: 8771061

4

Is iron involved in pathogenesis of Parkinson's disease--Mössbauer spectroscopy study of substantia nigra in control and disease brains.

Friedman A, Bauminger ER, Gałazka-Friedman J, Barcikowska M, Hechel D, Nowik I, Marczewska M. Friedman A, et al. Neurol Neurochir Pol. 1996;30 Suppl 2:95-103. Neurol Neurochir Pol. 1996. PMID: 9100247 No abstract available.

5

Controversies about iron in parkinsonian and control substantia nigra.

Gałazka-Friedman J, Friedman A. Gałazka-Friedman J, et al. Among authors: friedman a. Acta Neurobiol Exp (Wars). 1997;57(3):217-25. doi: 10.55782/ane-1997-1229. Acta Neurobiol Exp (Wars). 1997. PMID: 9407708 Free article. Review.

6

The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress.

Friedman A, Galazka-Friedman J. Friedman A, et al. Adv Neurol. 2001;86:137-42. Adv Neurol. 2001. PMID: 11553971 Review. No abstract available.

7

Swallowing disorders in Parkinson's disease.

Potulska A, Friedman A, Królicki L, Spychala A. Potulska A, et al. Among authors: friedman a. Parkinsonism Relat Disord. 2003 Aug;9(6):349-53. doi: 10.1016/s1353-8020(03)00045-2. Parkinsonism Relat Disord. 2003. PMID: 12853234

8

Iron and ferritin in hippocampal cortex and substantia nigra in human brain--implications for the possible role of iron in dementia.

Friedman A, Galazka-Friedman J, Bauminger ER, Koziorowski D. Friedman A, et al. J Neurol Sci. 2006 Oct 25;248(1-2):31-4. doi: 10.1016/j.jns.2006.05.056. Epub 2006 Jun 21. J Neurol Sci. 2006. PMID: 16797029

9

ELISA reveals a difference in the structure of substantia nigra ferritin in Parkinson's disease and incidental Lewy body compared to control.

Koziorowski D, Friedman A, Arosio P, Santambrogio P, Dziewulska D. Koziorowski D, et al. Among authors: friedman a. Parkinsonism Relat Disord. 2007 May;13(4):214-8. doi: 10.1016/j.parkreldis.2006.10.002. Epub 2007 Feb 1. Parkinsonism Relat Disord. 2007. PMID: 17275395

10

Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.

Koziorowski D, Friedman A. Koziorowski D, et al. Among authors: friedman a. Mov Disord. 2007 May 15;22(7):1033-6. doi: 10.1002/mds.21448. Mov Disord. 2007. PMID: 17370308 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,834 results

Search Page

Filters